Autopsy report · NCT01606111

The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery

“Poor patient recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 4 months before it started.
• Ran for about 1 year 10 months before it stopped.
• 46 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Ever Neuro Pharma GmbH

Sponsor type

Industry

Conditions

Traumatic Brain Injury

Interventions

Cerebrolysin; 0.9% NaCl, saline

Participants

46

Sites

1

Countries

Hong Kong

Trials that died the same way

• Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy
  “Low Patient Recruitment” (94% match in meaning)
• Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care
  “due to poor patient recruitment” (93% match in meaning)
• Macular Edema Incidence/Severity Reduction With Nevanac
  “Patient recruitment difficulties” (91% match in meaning)
• The Risk of Intraventricular Hemorrhage With Flat Midline Versus Right-Tilted Flat Lateral Head Positions
  “Due to low patient recruitment” (91% match in meaning)
• Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
  “Difficulties in patient recruitment” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.